Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,424.00
+5.50 (0.39%)
May 13, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Prescription Drugs | 281.03B |
Log In |
Log In |
Log In |
Log In |
Prescription Drugs Growth | 7.99% |
Log In |
Log In |
Log In |
Log In |
Over-the-counter Drugs | 11.24B |
Log In |
Log In |
Log In |
Log In |
Over-the-counter Drugs Growth | 5.78% |
Log In |
Log In |
Log In |
Log In |
Medical Equipment | 7.77B |
Log In |
Log In |
Log In |
Log In |
Medical Equipment Growth | 24.13% |
Log In |
Log In |
Log In |
Log In |
Other | 1.93B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 0.63% |
Log In |
Log In |
Log In |
Log In |
Other | 1.93B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 0.63% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Japan | 175.61B |
Log In |
Log In |
Log In |
Log In |
Japan Growth | -1.00% |
Log In |
Log In |
Log In |
Log In |
EMEA | 64.76B |
Log In |
Log In |
Log In |
Log In |
EMEA Growth | 23.31% |
Log In |
Log In |
Log In |
Log In |
China | 29.86B |
Log In |
Log In |
Log In |
Log In |
China Growth | 38.58% |
Log In |
Log In |
Log In |
Log In |
Asia | 28.67B |
Log In |
Log In |
Log In |
Log In |
Asia Growth | 18.86% |
Log In |
Log In |
Log In |
Log In |
Americas | 3.08B |
Log In |
Log In |
Log In |
Log In |
Americas Growth | -11.75% |
Log In |
Log In |
Log In |
Log In |